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Abstract 
Background: Hypothyroidism is a cause of left ventricular diastolic dysfunction especially in cases with positive 
history of coronary artery disease. It is suggested that cardiac dysfunction may be improved with thyroxin 
replacement therapy. However, it is controversial. Hence, in this study the efficacy of levothyroxine therapy on 
diastolic dysfunction in patients with subclinical hypothyroidism was assessed. 
Materials and Methods: In this, randomized clinical trial 40 consecutive patients with subclinical 
hypothyroidism attending to Loghman Hospital in 2018 for the treatment were enrolled. The treatment was 25-
50 microgram per day of levothyroxine for one year. During this period, the patients were followed up with visit 
or phone call with a monthly manner. The echocardiography indices were rechecked after one year beside the 
thyroid tests by initial lab and operators. 
Results: The mean BMI was significantly decreased (P=0.001). The T3 and TSH were significantly differed 
but The T4 had no significant alteration (P>0.05). Among the echocardiographic indices the MV.E, MV.A to 
MV. E ratio, EF, Eʹ septal, Eʹ lateral had significant increase and the MV.A and PV. Adur had significant 
reduction. After intervention among 40 patients, there were 17 cases with normal diastolic function. The BMI, 
MV. A, PV Adur, Eʹ Septal, Eʹ Lateral, and E to Eʹ ratio showed significant correlation. 
Conclusion: Totally, according to the obtained results, it is concluded that diastolic dysfunction as a common 
problem in patients with subclinical hypothyroidism may be treated with administration of levothyroxine. In 
addition, screening for diastolic dysfunction in patients with subclinical hypothyroidism is recommended to 
decrease the burden of problem.  
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Introduction 
Subclinical hypothyroidism is the conditions 
characterized with increased level dr_rgholami of 
thyroid stimulating hormone (TSH) despite normal 
serum level of free thyroxin. The serum level of TSH 
should be measured in cases with normal thyroxin 
levels suspected to have subclinical hypothyroidism. 
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Prevalence of hypothyroidism ranges from three to 
eight percent in general population. The prevalence 
increase with age and also it is more common among 
female subjects1-3. There are some debates about 
treatment of cases with TSH levels less than 10 
mu/ml2,5. Thyroxin replacement therapy would have 
no effect on improvement of survival or reduction of 
cardiovascular disorders. But it may result in 
improved left ventricular function and some serum 
lipid parameters2-5. Screening strategies are initiated at 
35 years and would be continued each five years. It 
has been suggested that screening would be more 
useful in women older than 50 years. Also it is 
important to screen and treat the pregnant women to 
decreased adverse fetal effects1-7. Also nearly 2-5 
percent of cases with sub-clinical hypothyroidism 
would develop annually overt hypothyroidism 
subsequently1-3. However the lipid abnormalities may 
improve after thyroxin replacement therapy the 
improvement in endothelial function and insulin 
resistance after replacement therapy has been also 
suggested1-5. 
The cardiac function and contractility are mediated by 
thyroid hormones by adenine cyclase enzyme 
resulting in increased heart rate1-5. However the other 
side effects such as myocardial infarction, aortic 
calcification, and cardiac dysfunctions are 
controversial5-10. Hypothyroidism is a cause of left 
ventricular diastolic dysfunction especially in cases 
with positive history of coronary artery disease11-14. It 
is suggested that cardiac dysfunction may be 
improved with thyroxin replacement therapy15-18. But 
it is controversial. Hence in this study the efficacy of 
levothyroxine therapy on diastolic dysfunction in 
patients with subclinical hypothyroidism was 
assessed. 
Methods 
In this randomized clinical trial 40 consecutive 
patients with subclinical hypothyroidism (according 
to two lab tests with three-month interval) attending to 
Loghman Hospital in 2018 for the treatment were 
enrolled. Exclusion criteria were hypertension, 
hyperlipidemia, diabetes mellitus, ischemic heart 
disease, renal failure, and smoking. The informed 
consent form was received from all patients and the 
study was approved by local ethical committee with 
approcal ode of Ir.sbm.msp.rec.1395890. Helsinki 
Declaration was respected across the study. 
All lab studies were done in single lab. The patients 
respecting all inclusion criteria were introduced to 
cardiologist and left ventricular diastolic function 
indices were determined by Echocardiography scale. 
Totally 130 patients were included among them finally 
40 subjects were enrolled in final analysis. The 
treatment was 25-50 microgram per day of 
levothyroxine for one year. During this period the 
patients were followed up with visit or phone call with 
a monthly manner. The echocardiography indices were 
rechecked after one year beside the thyroid tests by 
initial lab and operators. Also blinding was done for 
echocardiography operator. 
Data analysis was done by SPSS version 22.0 software 
among 40 patients including 20 male and 20 female 
subjects. The utilized tests were independent-sample-T 
and linear regression assays. The P values less than 0.05 
were considered statistically significant. 
Results 
The study was carried out among 20 men and 20 women 
with mean age of 45.9 ± 13.1 years. The baseline and 
after-one year results are demonstrated and compared 
in Table 1. As seen in this Table the mean BMI was 
significantly decreased (P=0.001).  
The T3 and TSH were significantly differed but The T4 
had no significant alteration (P > 0.05). Among the 
echocardiographic indices the MV.E, MV.A to MV. E 
ratio, EF, Eʹ septal, Eʹ lateral had significant increase 
and the MV.A and PV.Adur had significant reduction. 
After intervention among 40 patients there were 17 
cases with normal diastolic function. The BMI, MV. A, 
PV Adur, Eʹ Septal, Eʹ Lateral, and E to Eʹ ratio showed 
significant correlation (Table 2). 
Discussion 
Subclinical hypothyroidism is accompanied with left 
ventricular remodeling that is established by two-
dimensional and three-dimensional echocardiography 
that reveals diastolic dysfunction19-23. In addition, it 
would result in increased rate of coronary artery disease 
and dyslipidemia. We found that levothyroxine therapy 
decreased diastolic dysfunction in cases with 
subclinical hypothyroidism20-22. According to new 
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guidelines, the low-dose levothyroxine should be 
initiated in the patients with subclinical 
hypothyroidism23-30. In addition, screening by 
echocardiography in such patients is recommended. 
Regarding the increasing trend of hypothyroidism and 
increased related mortality and morbidity among 
patients especially due to heart failure further care for 
them is crucial. In our study, the mean age was in 
fourth life decade. The study by Yazici et al30 showed 
that patients were aging from 38 to 40 years. In 
addition, we found that majority of patients had high 
BMI but the levothyroxine therapy resulted in 
significant decrease in BMI. However, the narrow age 
range in current study could not miss the significant 
alterations. The study by Franzonia et al27 
demonstrated that BMI was same across the patients 
with subclinical hypothyroidism and euthyroid 
subjects. 
In our study, it was understood that levothyroxine use 
results in significant reduction in TSH level resulting in 
a mean in normal age in post-treatment stage. This 
matter was also seen in the study by Yazici et al30 but 
after six months of treatment. However, we had only 
two measurements and it is not clear that in which 
month the TSH was decreased initially to the normal 
serum level. After intervention the echocardiographic 
indices of MV.E, MV.A to MV. E ratio, EF, Eʹ septal, 
Eʹ lateral had significant increase and the MV.A and 
PV.Adur had significant reduction. In the other 
instances, there was no significant alteration. Franzonia 
et al27 revealed that Em and Em/Am ratio were 
significantly increased and the other indices had no 
significant alteration. For further understanding about 
the clinical relevance of these alterations in 
echocardiographic factors, further studies would be 
useful. 
Table 1: Baseline and after one year results. 
Value Std. Deviation Mean Variable 
0.000 3.15 25.9205 BMI before intervention 
2.94 25.2026 BMI after intervention 
0.000 1.99 8.5800 TSH before intervention 
0.70 1.4925 TSH after intervention 
0.055* 1.35 6.4775 T4 before intervention 
1.62 7.1700 T4 after intervention 
0.0001 18.67 108.77 T3 before intervention 
45.28 144.1750 T3 after intervention 
0.0019 0.084 0.5848 MV.E before intervention 
0.16 0.6710 MV.E after intervention 
0.003 0.08 0.7423 MV.A before intervention 
0.10 0.6873 MV.A after intervention 
0.003* 0.13 0.7965 MV.E.to.A before intervention 
0.33 1.0145 MV.E.to.A. after intervention 
0.763* 36.00 124.6000 PV.Adur before intervention 
20.48 117.2750 PV.Adur after intervention 
0.230 2.58 56.0000 EF before intervention 
0.31 57.0500 EF after intervention 
0.001* 0.09 0.0893 Eʹ Septal before intervention 
0.09 0.1010 Eʹ Septal after intervention 
0.040* 0.070 0.1170 E’ Lateral before intervention 
0.06 0.1340 EʹLateral after intervention 
0.996 1.57 7.9486 E.to.Eʹ before intervention 
1.313 7.9500 E.to.Eʹ after intervention 
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Erkan et al26 demonstrated that myocardial function 
had no significant alteration after intervention with 
levothyroxine but the mitral annular E velocity had 
significant improvement. It is in congruence relatively 
with our study. Improvement in diastolic function also 
is demonstrated with consideration of a healthy 
control group15. As shown in some studies30 the 
diastolic dysfunction is reversible in patients with 
subclinical hypothyroidism after levothyroxine 
replacement therapy. The correlation between the 
clinical and echocardiographic factors, in our study, 
demonstrates the importance of interventions 
according to the other contributing factors in these 
patients. 
Conclusion 
Totally, according to the obtained results, it is 
concluded that diastolic dysfunction as a common 
problem in patients with subclinical hypothyroidism 
may be treated with administration of levothyroxine. 
In addition, screening for diastolic dysfunction in 
patients with subclinical hypothyroidism is 
recommended to decrease the burden of problem. 
However further studies with larger sample size and 
multi-center samplings are required to attain results 
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